版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
HypersensitivityJianzhongChenchenjianzhong@Hypersensitivity
(hypersensitivityreaction)referstoundesirablereactionsproducedbythenormalimmunesystem.Thesereactionsmaybedamaging,uncomfortable,oroccasionallyfatal.Hypersensitivityreactionsrequireapre-sensitized(immune)stateofthehost.
IntroductionClassificationofHypersensitivityTypeI
hypersensitivity
(immediatehypersensitivity)
(anaphylaxis)TypeI
hypersensitivityImmediatehypersensitivityisarapid,IgEantibody-andmastcell-mediatedvascularandsmoothmusclereaction,oftenfollowedbyinflammation,thatoccursinsomeindividualsonencounterwithcertainforeignantigenstowhichtheyhavebeenexposedpreviously.
Immediatehypersensitivityreactionsarealsocalledallergy,oratopy
I.CharacteristicsofTypeI
hypersensitivity1.Rapid:reactanddisappearquicklyonre-exposuretoAg2.Dysfunction:dysfunctionratherthanseveretissueandcelldamageoccurs3.Stronghereditarytendency:obviousindividualdifferenceandgeneticcorrelationAllergens
areproteinsorchemicalsboundtoproteinsthatinduceIgEantibodyresponsesandelicitanimmediatehypersensitivity(allergic)reaction
inatopicindividuals.
II.ComponentsinvolvedintypeIhypersensitivityTypesofallergiesInhalant:Pollensandmolds;Animalsdander;DustmitesIngestant:Food(mostcommonlypeanuts,dairy,egg,fishandshellfish)Injectant:Stinginginsects;DrugsContactant:drug,IvyIgEisaspecificIgthatgivesriseinimmediatehypersensitivity.MostallergicIgEresponseoccuronmucousmembranesurfacesinresponsetoallergensthatenterthebodybyeitherinhalationoringestion.II.ComponentsinvolvedintypeIhypersensitivityIgEsynthesisisdependentontheactivationofCD4+helperTcellsoftheTH2subsetandtheirsecretionofIL-4.
IL-4promoteIgEswitchingIL-5activateseosinophils,acelltypethatisabundantinmanyimmediatehypersensitivityreactions.IL-13stimulatesepithelialcells(e.g.,intheairways)tosecreteincreasedamountsofmucus,andexcessivemucusproductionisalsoacommonfeatureofthesereactions.TH2cellscontributetotheinflammationofthelate-phasereaction.StructureandFunctionoftheFcRⅠFcεRI,thatisexpressedonmastcells,basophils,andeosinophils.TheaffinityofFcεRIforIgEisveryhigh(Kd=1×10-10M)
mastcells,basophilsandeosinophilsmastcellsarefoundthroughoutconnectivetissue,particularlynearbloodandlymphaticvessels.Basophilsmainlycirculateintheblood.Eosinophilsaremainlylocatedinsub-epithelialconnectivetissuesofmucousmembranesurfacesoftherespiratoryandgastrointestinaltracts.Someintheperipheralblood.MastcellMastcellMastcellactivationBiochemicaleventsinmastcellactivationIII.PathogenicmechanismsIII.PathogenicmechanismsEffectorphaseImmediatephaseTheimmediatephaseoftheinflammatoryresponseisduetopreformedmediators(especiallyhistamine)storedinthemastcellgranulesandalsotocertainrapidlysynthesizedarachidonatederivatives.Itreachesmaximalintensitywithinabout15minutesafterantigenre-exposure.Thisphaseischaracterizedgrosslybyerythema,localizededemaintheformofawheal,induration,warmth,pruritus,andaburningsensationattheaffectedsite.LatephaseManifestationofthelatephasearedueinparttopresynthesizedTNF-andinparttoothermediators(principallyPAF,LT,IL-4,etc.)whosesynthesisbeginsafterthemastcelldegranulates.Theeffectsofthesemediatorsbecomeapparentabout6hoursafterantigencontactandaremarkedbyaninfiltrationofeosinophilsandneutrophils.IV.TypeIhypersensitivity-
associateddiseasesV.Immunoprophylaxis&immunotherapy1.SkintesttoidentifyallergenandavoidtheoffendingallergenV.Immunoprophylaxis&immunotherapy2.Hyposensitizationordesensitizationwithallergens1)Forantitoxin:stimulationwithsmalldoseofAgprovokesaminimalamountofmediatorsrelease,andthelatterarerapidlyresolved.2)ForspecificallergensGraduallyincreasingquantitiesofAgareinjectedsubcutaneously.ThisisaformofimmunotherapyaimedatstimulatingtheproductionofIgGblockingantibodythatbindstheoffendingantigenandpreventsitscombiningtoIgE.TheresponsetotreatmentincludesanincreaseinIgGantibodies,adecreaseinIgEantibodiesintheserum.TherapyImmunotherapyAllergen+IL-12DNAvaccineHumanizedMoAbsIL-4RTheProtectiveRolesofIgE-andMastCell-MediatedImmuneReactionsAmajorprotectivefunctionofIgE-initiatedimmunereactionsistheeradicationofparasites.
Mastcellsplayanimportantprotectiveroleaspartoftheinnateimmuneresponsetobacterialinfections.
THEPROTECTIVEROLESOFIgE-ANDMASTCELL–
MEDIATEDIMMUNEREACTIONSActivationofeosinophilstokillhelminthsTypeII
hypersensitivity
(cytotoxictype)TypeII
hypersensitivityreactionsaremediatedbyIgGandIgMantibodybindingtospecificcellsortissues.Thedamagecausedisthusrestrictedtothespecificcellsortissuesbearingtheantigen.Theantibodiesdamagecellsandtissuesbyactivatingcomplement,andbybindingandactivatingeffectorcellscarryingFcR.I.Pathogenicmechanisms
Agsonthesurfaceoftargetcells↓
body→IgG,IgM
↓
1.damagethetargetcell
1)
activationofcomplement2)
opsonizationorADCC
FcRC3bR
2.targetcelldysfunctionEffectormechanismsofAb-mediateddiseasesII.ClinicaldiseaseTransfusionreactionsBloodGroupAgs
BloodGroupAgAbAAanti-BBBanti-AABA&BNoneO----anti-A&anti-BAbsagainstbloodgroupAgsarenaturallypresentandareIgMtype.TransfusionReaction:+ComplementFcKcelllysisResult:AnaphylacticShockduetoComplementactivation.RBCRBCIgMII.Clinicaldisease2.HemolyticdiseaseofthenewbornoccurswhenanRh-mothergivesbirthtoanRh+infant.
Prophylaxis(RhoGAM)RhD-vemotherRhD+vefetusAnti-RhDAbsRhD+vefetusTheadministrationofanti-RhAbtoanRh-motherwithin72hoursofdeliveringanRh+infantwillpreventsensitizationandproblemswithsubsequentpregnancies.II.Clinicaldisease3.
AutoimmunehemolyticdiseaseSomedrugsorvirusesstimulateAbformationbychangingtheerythrocytesurfacecomponentstoformnewepitopes.4.
Drug-inducedreactiontoblood
componentsThesediseaseshavebeenassociatedwithmanydifferentchemotherapeutics,suchaspenicillin,thesulfonamidesandcytotoxicdrugs.Drug-inducedreactiontoblood
componentsRedcells:Penicillin,chloropromazine,phenacetinGranulocytes:Quinidine,amidopyridinePlatelets:sulphonamides,thiazidesHumanantibody-mediateddiseasesThepatientsproduceantibodiestothyrotropin(thyroidstimulatinghormone,TSH)receptor.Theendresultisoverproductionofthyroidhormoneandhyperthyroidism5.GravesdiseaseTypeIII
hypersensitivity
(immunecomplextype)Immunecomplexes(IC)depositinbasementmembranesofsmallbloodvesselsinvariousorgans.FeaturesThepathologicfeaturesofdiseasescausedbyimmunecomplexesreflectthesiteofimmunecomplexdepositionandarenotdeterminedbythecellularsourceoftheantigenandantigenissolubleImmunecomplex–mediateddiseasestendtoaffectmultipletissuesandorgans,althoughsomeareparticularlysusceptible,suchaskidneysandjoints.Ag+AbImmunecomplex,ICLargeICPhagocytosisbyphagocytesSmallICDischargedfromcirculationMediumICExistincirculation,anddepositMechanismoftypeIIIhypersensitivity
1.FormationofmediumimmunecomplexDepositionofICintissuesAnincreaseinvascularpermeabilityIngeneral,complement,mastcells,basophilsandplateletsmustallbeconsideredaspotentialproducersofvasoactiveamines.LocalhighbloodpressureandturbulenceThebloodpressureintheglomerularcapillariesisapproximatelyfourtimesthatofmostothercapillaries.ICarecapableoftriggeringavarietyofinflammatoryprocessesICsinteractwiththecomplementsystemtogenerateC3aandC5a.Thesecomplementfragmentsstimulatethereleaseofvasoactiveaminesandarechemotacticfactorsformastcellsandbasophils,eosinophilsandneutrophils.ICsinteractdirectlywithbasophilsandplatelets(viaFcR)toinducethereleaseofvasoactiveamines.NeutrophilsexocytosetheirlysosomalenzymesontothesiteofICdepositionanddamagetheunderlyingtissue.HumanimmunecomplexdiseaseSequenceofimmunologicresponsesinexperimentalacuteserumsickness.Becausethecomplexesaredepositedmainlyinsmallarteries,renalglomeruli,andthesynoviaofjoints,theclinicalandpathologicmanifestationsarevasculitis,nephritis,andarthritis.Hemorrhagingoftheskininthecourseofaserum-sicknessreaction.Urticarialrashasaconsequenceofaserum-sicknessreaction.Arthus’sreaction:Alocalizedformofexperimentalimmunecomplex–mediatedvasculitisiscalledtheArthusreaction.TypeIV
hypersensitivity
(T-cellmediateddiseases)DelayedtypehypersensitivityisinitiatedbysensitizedTcellsreactingwithspecificantigens.Thereactionsaremanifestasinflammationatthesiteofantigenexposure,whichusuallypeaks24-72hoursafterexposure.Thisreactionisindependentofantibodyandcomplement.I.PathogenicmechanismsII.Clinicaldiseases1.InfectiousDTH
Intheinfectiveprocess,intracellularparasiticalbacteria(Mycobacteriumtuber
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025-2030智慧农业的错误备注废弃物资源化利用可持续发展研究资产报告
- 2025-2030智慧农业机械设备行业市场供需分析及投资前景规划评估研究
- 选煤厂提质增效改造工程投标书
- 云南普洱会计从业资格证考试及答案解析
- 护理预防医学简答题题库及答案解析
- 护理正高答辩题库及答案解析
- 热电联产建设项目申请报告
- 计算机金融从业资格考试及答案解析
- 安全员实操技能大赛题库及答案解析
- 房建防洪安全培训试题及答案解析
- 公务礼仪培训课件
- 2025年秋新北师大版数学3年级上册全册同步教案
- 插秧机培训课件
- 医疗器械批发行业的合规风险与解决方案研究-洞察及研究
- 学校承接社会考试应急预案(3篇)
- 外研版(2024)八年级上册英语单词默写练习表
- 肝癌肝动脉化疗栓塞护理查房
- 高中数学作业智能批改系统研究
- 人工智能应用案例讲解
- 企业组织结构对创新及创新活动的影响
- 肝胆胰腺外科进修汇报
评论
0/150
提交评论